| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/159.4.610 |
| P698 | PubMed publication ID | 2647859 |
| P50 | author | Per Ljungman | Q52717443 |
| Per Bolme | Q78032524 | ||
| P2093 | author name string | Ringdén O | |
| Böttiger M | |||
| Linde A | |||
| Wahren B | |||
| Gahrton G | |||
| Lönnqvist B | |||
| Fridell E | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | measles | Q79793 |
| rubella | Q155857 | ||
| attenuated vaccine | Q1810913 | ||
| mumps | Q176741 | ||
| P304 | page(s) | 610-615 | |
| P577 | publication date | 1989-04-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine | |
| P478 | volume | 159 |
| Q34390072 | 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host |
| Q38253061 | Analysis of factors affecting immune recovery and initial response to tetanus after DTaP vaccination in pediatric allogeneic HSCT patients |
| Q55364518 | Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). |
| Q36740113 | Challenges and pitfalls in prenatal screening in pregnancies involving allogeneic stem cell transplantation recipients |
| Q38060559 | Clinical practice implications of immunizations after pediatric bone marrow transplant: a literature review |
| Q40774499 | Critical appraisal of immunization strategies for prevention of infection in the compromised host. |
| Q45780856 | Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors |
| Q39199975 | Early measles vaccination in bone marrow transplant recipients |
| Q37704224 | Epidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center |
| Q28388806 | Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective |
| Q40781325 | Immune reconstitution following bone marrow transplantation |
| Q36170623 | Immunization for bone marrow transplant recipients |
| Q35622750 | Immunization of children after solid organ transplantation |
| Q30401036 | Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases |
| Q37320197 | Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review |
| Q41561698 | Immunological reconstitution following bone marrow transplantation |
| Q37150434 | Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. |
| Q50927965 | Influenza vaccination following liver transplantation in children. |
| Q41696144 | International travel patterns and travel risks for stem cell transplant recipients |
| Q77482823 | Late complications after bone marrow transplantation in children and adolescents |
| Q41557335 | Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis |
| Q38034395 | Live (vaccines) from New York |
| Q45419473 | Live virus immunization after orthotopic liver transplantation |
| Q38419551 | Live virus vaccines in transplantation: friend or foe? |
| Q47785365 | Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants |
| Q80427681 | Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease |
| Q72803985 | Measles vaccination after orthotopic liver transplantation |
| Q24555612 | Mumps and the UK epidemic 2005 |
| Q72457833 | Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction |
| Q37687969 | Post-hematopoietic stem cell transplant immunization practices in the Pediatric Blood and Marrow Transplant Consortium |
| Q38387297 | Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection? |
| Q35072259 | Recommendations for immunizations in stem cell transplantation |
| Q40502412 | Reimmunization after allogeneic bone marrow transplantation |
| Q36124964 | Reimmunization after hematopoietic stem cell transplantation |
| Q36355144 | Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies |
| Q46629483 | Seroprevalence of viral childhood infections in Eritrea |
| Q45187834 | Significant loss of hepatitis A Ab after allogeneic hematopoietic SCT in pediatric patients |
| Q37469283 | The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies |
| Q24533456 | Use of licensed vaccines for active immunization of the immunocompromised host |
| Q37846281 | Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. |
| Q78761080 | Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study |
| Q91465246 | Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) |
| Q37359322 | Vaccination of hematopoietic stem cell transplantation recipients: perspective in Korea. |
| Q81483927 | Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT |
| Q26829398 | Vaccination recommendations for the hematology and oncology and post-stem cell transplant populations |
| Q27477631 | Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols |
| Q73747937 | Vaccines for transplant recipients |
| Q37824989 | Viral infections in immunocompromised patients |
| Q99567976 | [Is complete immunity against measles a realistic target for patients with rheumatic diseases and how can it possibly be achieved?] |
| Q64988150 | [Post-transplantation vaccination of bone-marrow transplant recipients]. |
Search more.